Kashiwagi Nobuo, Fujii Takashi, Nishiyama Kinji, Nakanishi Katsuyuki, Tomiyama Noriyuki, Yagyu Yukinobu, Tsurusaki Masakatsu, Kitano Mutsukazu, Murakami Takamichi
Department of Radiology, Kinki University School of Medicine, Osakasayama
Department of Otolaryngology, Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Higashinari.
Jpn J Clin Oncol. 2015 Apr;45(4):378-80. doi: 10.1093/jjco/hyu227. Epub 2015 Feb 5.
A case of advanced parotid cancer in which long-term control was achieved by superselective intra-arterial cisplatin infusion with concomitant radiotherapy is reported. A 63-year-old woman with parotid squamous cell carcinoma was referred to our hospital. Magnetic resonance images revealed extraparotid extension of the tumor, indicating that complete resection would be difficult. Consequently, intra-arterial cisplatin infusion with concomitant radiotherapy was planned as an alternative therapy. Superselective intra-arterial infusion of cisplatin (100 mg/m(2)) was performed six times, at intervals of 7-9 days. The arteries chosen for superselective infusion were the posterior auricular artery, the transverse facial artery and the intrinsic parotid artery originating directly from the external carotid artery. Concurrently, external radiotherapy of a total of 50 Gy in 25 fractions was also performed. The patient achieved a complete response and has remained free of disease recurrence 5 years after treatment. Intra-arterial cisplatin infusion with concomitant radiotherapy can be a practical option for patients with unresectable parotid squamous cell carcinoma.
报告了一例晚期腮腺癌患者,通过超选择性动脉内顺铂灌注联合放射治疗实现了长期控制。一名63岁患有腮腺鳞状细胞癌的女性被转诊至我院。磁共振成像显示肿瘤侵犯腮腺外,提示难以完全切除。因此,计划将动脉内顺铂灌注联合放射治疗作为替代疗法。超选择性动脉内顺铂灌注(100 mg/m²)共进行6次,间隔7 - 9天。超选择性灌注所选动脉为耳后动脉、面横动脉以及直接发自颈外动脉的腮腺内动脉。同时,还进行了总量为50 Gy、分25次的外照射放疗。患者获得了完全缓解,治疗后5年无疾病复发。动脉内顺铂灌注联合放射治疗对于无法切除的腮腺鳞状细胞癌患者可能是一种可行的选择。